Feedback / Questions
rugonersen (RG6091) - Oak Hill Bio
https://www.businesswire.com/news/home/20250415795863/en/Oak-Hill-Bio-Enters-into-Exclusive-License-Agreement-with-Roche-to-Obtain-Global-Rights-for-a-Phase-3-Ready-Potential-Best-in-Class-Treatment-for-Individuals-with-Angelman-Syndrome
Apr 15, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next